| Pfizer is a research-based biopharmaceutical company. Co.'s portfolio includes medicines and vaccines, as well as consumer healthcare products. Co. manages its commercial operations through three businesses: Pfizer Biopharmaceuticals Group, which includes Co.'s health business units (except Consumer Healthcare) as well as a hospital business unit that commercializes its portfolio of sterile injectable and anti-infective medicines; Upjohn, which includes Co.'s solid oral dose brands such as Lyrica, Lipitor, Norvasc, Viagra and Celebrex, as well as certain generic medicines; and Consumer Healthcare, which is an over-the-counter medicines business. We show 37 historical shares outstanding datapoints in our coverage of PFE's shares outstanding history.|
Understanding the changing numbers of Pfizer shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like Pfizer versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching Pfizer by allowing them to research Pfizer shares outstanding history
as well as any other stock in our coverage universe.